[-] Show simple item record

dc.contributor.authorGordon, Laureneng
dc.contributor.authorThakur, Netraeng
dc.contributor.authorAtlas, Michel C.eng
dc.date.issued2007eng
dc.description.abstractDepot medroxyprogesterone acetate (DMPA; Depo-Provera) and the combination contraceptive vaginal ring (NuvaRing) are most effective for obese women because they don't appear to be affected by body weight (strength of recommendation [SOR]: B, consistent cohort studies).eng
dc.identifier.urihttp://hdl.handle.net/10355/3644eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2007 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 56, no. 06 (June 2007): 471-473eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectbody weighteng
dc.subjectbirth controleng
dc.subjectDepo-Proveraeng
dc.subjectNuvaRingeng
dc.subject.lcshOral contraceptiveseng
dc.subject.lcshObesity in womeneng
dc.subject.lcshContraceptives, Vaginaleng
dc.titleWhat hormonal contraception is most effective for obese women?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record